Levi A. Garraway

148.4k total citations · 10 hit papers
173 papers, 22.5k citations indexed

About

Levi A. Garraway is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Levi A. Garraway has authored 173 papers receiving a total of 22.5k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Molecular Biology, 73 papers in Cancer Research and 45 papers in Oncology. Recurrent topics in Levi A. Garraway's work include Cancer Genomics and Diagnostics (68 papers), Melanoma and MAPK Pathways (40 papers) and Genetic factors in colorectal cancer (15 papers). Levi A. Garraway is often cited by papers focused on Cancer Genomics and Diagnostics (68 papers), Melanoma and MAPK Pathways (40 papers) and Genetic factors in colorectal cancer (15 papers). Levi A. Garraway collaborates with scholars based in United States, Germany and Switzerland. Levi A. Garraway's co-authors include Eric S. Lander, Matthew Meyerson, Lynda Chin, William R. Sellers, Gad Getz, Todd R. Golub, David E. Fisher, Laura E. MacConaill, Gregory V. Kryukov and Stacey Gabriel and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Levi A. Garraway

171 papers receiving 22.2k citations

Hit Papers

Discovery and saturation ... 2005 2026 2012 2019 2014 2013 2005 2016 2005 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Discovery and saturation analysis of cancer genes across 21 tumour types
    2014 2.1k citations Levi A. Garraway, Todd R. Golub et al. profile →
  2. Highly Recurrent TERT Promoter Mutations in Human Melanoma
    2013 1.3k citations Gregory V. Kryukov, Lynda Chin et al. Science profile →
  3. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
    2005 1.1k citations Levi A. Garraway, Hans R. Widlund et al. profile →
  4. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
    2016 1.1k citations Himisha Beltran, Davide Prandi et al. profile →
  5. BRAF mutation predicts sensitivity to MEK inhibition
    2005 1.0k citations Levi A. Garraway, Gad Getz et al. profile →
  6. Lessons from the Cancer Genome
    2013 883 citations Levi A. Garraway et al. profile →
  7. Recurrent BRAF mutations in Langerhans cell histiocytosis
    2010 742 citations Laura E. MacConaill, Sarah M. Kehoe et al. profile →
  8. Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
    2011 732 citations Nikhil Wagle, Michael F. Berger et al. Journal of Clinical Oncology profile →
  9. Quantitative Proteomics of the Cancer Cell Line Encyclopedia
    2020 574 citations Mahmoud Ghandi, Judit Jané‐Valbuena et al. profile →
  10. A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
    2014 357 citations David J. Konieczkowski, Cory M. Johannessen et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Levi A. Garraway United States 68 14.9k 7.0k 5.6k 3.9k 2.6k 173 22.5k
Michael J. Birrer United States 83 13.5k 0.9× 9.5k 1.3× 5.1k 0.9× 2.5k 0.6× 2.5k 1.0× 434 25.4k
Ivan Bièche France 76 11.1k 0.7× 5.9k 0.8× 5.7k 1.0× 2.6k 0.7× 1.7k 0.6× 497 20.2k
Siraj M. Ali United States 68 15.8k 1.1× 8.8k 1.3× 4.7k 0.8× 6.6k 1.7× 3.4k 1.3× 381 27.2k
Elisa de Stanchina United States 65 13.8k 0.9× 7.0k 1.0× 4.9k 0.9× 3.0k 0.8× 1.5k 0.6× 226 19.4k
Kenneth Aldape United States 90 13.1k 0.9× 6.6k 0.9× 8.1k 1.4× 4.8k 1.2× 1.7k 0.7× 369 27.8k
Anil K. Rustgi United States 73 9.9k 0.7× 9.6k 1.4× 4.1k 0.7× 2.9k 0.7× 1.5k 0.6× 302 20.2k
Mauro Delorenzi Switzerland 66 9.2k 0.6× 8.0k 1.1× 5.9k 1.1× 2.4k 0.6× 3.0k 1.2× 193 19.0k
Neal Rosen United States 100 24.7k 1.7× 12.2k 1.7× 4.2k 0.8× 5.7k 1.5× 3.5k 1.3× 255 34.8k
Erik Larsson Sweden 56 21.9k 1.5× 8.3k 1.2× 9.7k 1.7× 6.9k 1.8× 2.7k 1.0× 208 34.1k
Owen J. Sansom United Kingdom 80 14.4k 1.0× 8.8k 1.3× 4.9k 0.9× 1.6k 0.4× 1.9k 0.7× 311 23.8k

Countries citing papers authored by Levi A. Garraway

Since Specialization
Citations

This map shows the geographic impact of Levi A. Garraway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levi A. Garraway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levi A. Garraway more than expected).

Fields of papers citing papers by Levi A. Garraway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levi A. Garraway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levi A. Garraway. The network helps show where Levi A. Garraway may publish in the future.

Co-authorship network of co-authors of Levi A. Garraway

This figure shows the co-authorship network connecting the top 25 collaborators of Levi A. Garraway. A scholar is included among the top collaborators of Levi A. Garraway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levi A. Garraway. Levi A. Garraway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amin‐Mansour, Ali, Suzanne George, Stefano Sioletic, et al.. (2019). Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma. Clinical Cancer Research. 25(16). 5135–5142. 18 indexed citations
2.
Horn, Thomas, Stéphane Ferretti, Nicolas Ebel, et al.. (2016). High-Order Drug Combinations Are Required to Effectively Kill Colorectal Cancer Cells. Cancer Research. 76(23). 6950–6963. 24 indexed citations
3.
Le, Xiuning, Pedram Razavi, Daniel J. Treacy, et al.. (2016). Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer. Cancer Discovery. 6(10). 1134–1147. 97 indexed citations
4.
Botta, Ginevra, Shuai Gao, Tiantian Li, et al.. (2015). PLZF, a Tumor Suppressor Genetically Lost in Metastatic Castration-Resistant Prostate Cancer, Is a Mediator of Resistance to Androgen Deprivation Therapy. Cancer Research. 75(10). 1944–1948. 46 indexed citations
5.
Whittaker, Steven R., Glenn S. Cowley, Steve Wagner, et al.. (2015). Combined Pan-RAF and MEK Inhibition Overcomes Multiple Resistance Mechanisms to Selective RAF Inhibitors. Molecular Cancer Therapeutics. 14(12). 2700–2711. 55 indexed citations
6.
Kryukov, Gregory V., Craig M. Bielski, Kaitlin E. Samocha, et al.. (2015). Genetic Effect of Chemotherapy Exposure in Children of Testicular Cancer Survivors. Clinical Cancer Research. 22(9). 2183–2189. 14 indexed citations
7.
Konieczkowski, David J., Cory M. Johannessen, Omar O. Abudayyeh, et al.. (2014). A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors. Cancer Discovery. 4(7). 816–827. 357 indexed citations breakdown →
8.
Theurillat, Jean‐Philippe, Namrata D. Udeshi, Wesley J. Errington, et al.. (2014). Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer. Science. 346(6205). 85–89. 168 indexed citations
9.
Pop, Marius S., Nicolas Stransky, Colin W. Garvie, et al.. (2014). A Small Molecule That Binds and Inhibits the ETV1 Transcription Factor Oncoprotein. Molecular Cancer Therapeutics. 13(6). 1492–1502. 49 indexed citations
10.
Prandi, Davide, Sylvan C. Baca, Alessandro Romanel, et al.. (2014). Unraveling the clonal hierarchy of somatic genomic aberrations. Genome biology. 15(8). 439–439. 59 indexed citations
11.
Goetz, Eva M., Mahmoud Ghandi, Daniel J. Treacy, Nikhil Wagle, & Levi A. Garraway. (2014). ERK Mutations Confer Resistance to Mitogen-Activated Protein Kinase Pathway Inhibitors. Cancer Research. 74(23). 7079–7089. 80 indexed citations
12.
Wagle, Nikhil, Michael F. Berger, Matthew J. Davis, et al.. (2011). Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling. Journal of Clinical Oncology. 29(22). 3085–3096. 732 indexed citations breakdown →
13.
Wagle, Nikhil, Michael F. Berger, Matthew J. Davis, et al.. (2011). High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel Sequencing. Cancer Discovery. 2(1). 82–93. 384 indexed citations
14.
Park, Eun Sung, Rosalia Rabinovsky, Mark Carey, et al.. (2010). Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set. Molecular Cancer Therapeutics. 9(2). 257–267. 71 indexed citations
15.
Jané‐Valbuena, Judit, Hans R. Widlund, Sven Perner, et al.. (2010). An Oncogenic Role for ETV1 in Melanoma. Cancer Research. 70(5). 2075–2084. 81 indexed citations
16.
Modrek, Barmak, Lin Ge, Ajay Pandita, et al.. (2009). Oncogenic Activating Mutations Are Associated with Local Copy Gain. Molecular Cancer Research. 7(8). 1244–1252. 51 indexed citations
17.
Lin, William M., Alissa C. Baker, Rameen Beroukhim, et al.. (2008). Modeling Genomic Diversity and Tumor Dependency in Malignant Melanoma. Cancer Research. 68(3). 664–673. 215 indexed citations
18.
Ji, Hongbin, Zhenxiong Wang, Samanthi A. Perera, et al.. (2007). Mutations in BRAF and KRAS Converge on Activation of the Mitogen-Activated Protein Kinase Pathway in Lung Cancer Mouse Models. Cancer Research. 67(10). 4933–4939. 137 indexed citations
19.
Zhao, Xiaojun, Barbara A. Weir, Thomas LaFramboise, et al.. (2005). Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis. Cancer Research. 65(13). 5561–5570. 242 indexed citations
20.
Späth, Gérald F., Levi A. Garraway, Salvatore J. Turco, & Stephen M. Beverley. (2003). The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proceedings of the National Academy of Sciences. 100(16). 9536–9541. 219 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael J. Birrer Breakdown of academic impact, for papers by Ivan Bièche Breakdown of academic impact, for papers by Siraj M. Ali Breakdown of academic impact, for papers by Elisa de Stanchina Breakdown of academic impact, for papers by Kenneth Aldape Breakdown of academic impact, for papers by Anil K. Rustgi Breakdown of academic impact, for papers by Mauro Delorenzi Breakdown of academic impact, for papers by Neal Rosen Breakdown of academic impact, for papers by Erik Larsson Breakdown of academic impact, for papers by Owen J. Sansom
Rankless by CCL
2026